1. Home
  2. WLY vs AMPH Comparison

WLY vs AMPH Comparison

Compare WLY & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • AMPH
  • Stock Information
  • Founded
  • WLY 1807
  • AMPH 1996
  • Country
  • WLY United States
  • AMPH United States
  • Employees
  • WLY N/A
  • AMPH N/A
  • Industry
  • WLY Books
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLY Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • WLY Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • WLY 2.1B
  • AMPH 1.1B
  • IPO Year
  • WLY N/A
  • AMPH 2014
  • Fundamental
  • Price
  • WLY $43.29
  • AMPH $23.20
  • Analyst Decision
  • WLY
  • AMPH Hold
  • Analyst Count
  • WLY 0
  • AMPH 5
  • Target Price
  • WLY N/A
  • AMPH $38.00
  • AVG Volume (30 Days)
  • WLY 709.9K
  • AMPH 493.6K
  • Earning Date
  • WLY 06-17-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • WLY 3.26%
  • AMPH N/A
  • EPS Growth
  • WLY N/A
  • AMPH N/A
  • EPS
  • WLY 1.53
  • AMPH 2.77
  • Revenue
  • WLY $1,677,609,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • WLY $1.75
  • AMPH $0.67
  • Revenue Next Year
  • WLY $2.40
  • AMPH $5.18
  • P/E Ratio
  • WLY $28.29
  • AMPH $8.39
  • Revenue Growth
  • WLY N/A
  • AMPH 8.05
  • 52 Week Low
  • WLY $36.50
  • AMPH $22.64
  • 52 Week High
  • WLY $53.96
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • WLY 56.41
  • AMPH 37.07
  • Support Level
  • WLY $43.05
  • AMPH $22.81
  • Resistance Level
  • WLY $45.64
  • AMPH $24.52
  • Average True Range (ATR)
  • WLY 1.40
  • AMPH 0.74
  • MACD
  • WLY 0.31
  • AMPH -0.22
  • Stochastic Oscillator
  • WLY 74.29
  • AMPH 11.27

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: